levodopa has been researched along with alpha-aminopyridine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Genovese, N; Klawans, HL | 1 |
| Komajda, M | 1 |
| Andersson, O; Grillner, S | 1 |
| Zangger, P | 1 |
| Block, F; Nolden-Koch, M; Pergande, G; Purr, J; Schwarz, M | 1 |
| Pergande, G; Schmidt, WJ; Schuster, G; Wacker, E | 1 |
| Evert, BO; Klockgether, T; Kovar, KA; Rundfeldt, C; Schulz, JB; Seyfried, J; Wüllner, U | 1 |
1 review(s) available for levodopa and alpha-aminopyridine
| Article | Year |
|---|---|
Pharmacology of dementia.
Topics: 4-Aminopyridine; Acetylcholine; Adenosine Triphosphate; Aged; Aminopyridines; Central Nervous System Stimulants; Cerebrovascular Circulation; Clinical Trials as Topic; Dementia; Double-Blind Method; Humans; Levodopa; Nafronyl; Narcotic Antagonists; Nerve Tissue Proteins; Parasympathomimetics; Pentylenetetrazole; Physostigmine; Piracetam; Procainamide; Vasodilator Agents; Vasopressins | 1986 |
1 trial(s) available for levodopa and alpha-aminopyridine
| Article | Year |
|---|---|
Pharmacology of dementia.
Topics: 4-Aminopyridine; Acetylcholine; Adenosine Triphosphate; Aged; Aminopyridines; Central Nervous System Stimulants; Cerebrovascular Circulation; Clinical Trials as Topic; Dementia; Double-Blind Method; Humans; Levodopa; Nafronyl; Narcotic Antagonists; Nerve Tissue Proteins; Parasympathomimetics; Pentylenetetrazole; Physostigmine; Piracetam; Procainamide; Vasodilator Agents; Vasopressins | 1986 |
6 other study(ies) available for levodopa and alpha-aminopyridine
| Article | Year |
|---|---|
[New cardiotonic agents].
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Colforsin; Deoxyepinephrine; Humans; Imidazoles; Levodopa; Milrinone; Practolol; Prenalterol; Propanolamines; Pyridones; Quinazolines; Xamoterol | 1985 |
Peripheral control of the cat's step cycle. II. Entrainment of the central pattern generators for locomotion by sinusoidal hip movements during "fictive locomotion.".
Topics: 4-Aminopyridine; Aminopyridines; Animals; Cats; Curare; Denervation; Hindlimb; Hip Joint; Levodopa; Locomotion; Movement; Neuromuscular Junction; Peripheral Nerves; Spinal Nerves; Synaptic Transmission | 1983 |
The effect of 4-aminopyridine on the spinal locomotor rhythm induced by L-DOPA.
Topics: 4-Aminopyridine; Aminopyridines; Animals; Cats; Dose-Response Relationship, Drug; Levodopa; Locomotion; Movement; Muscles; Neuromuscular Depolarizing Agents; Nialamide; Spinal Cord | 1981 |
Antiparkinsonian effect of flupirtine in monoamine-depleted rats.
Topics: Aminopyridines; Analgesics; Animals; Antiparkinson Agents; Biogenic Monoamines; Drug Synergism; Electromyography; Levodopa; Male; Neuroprotective Agents; Parkinson Disease, Secondary; Rats; Rats, Wistar | 1996 |
Antiparkinsonian and other motor effects of flupirtine alone and in combination with dopaminergic drugs.
Topics: Aminopyridines; Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Dextroamphetamine; Dose-Response Relationship, Drug; Grooming; Levodopa; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1997 |
Flupirtine and retigabine prevent L-glutamate toxicity in rat pheochromocytoma PC 12 cells.
Topics: Aminopyridines; Analgesics; Animals; Antidepressive Agents; Carbamates; Cell Death; Clorgyline; Culture Media; Cystine; Dopamine Agents; Excitatory Amino Acid Antagonists; Glutamic Acid; Glutathione; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; PC12 Cells; Phenylenediamines; Rats; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate | 2000 |